Ligandal Patents – Insights & Stats (Updated 2023)

Ligandal has a total of 56 patents globally, out of which 2 have been granted. Of these 56 patents, more than 75% patents are active. The United States of America is where Ligandal has filed the maximum number of patents, followed by Japan and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Ligandal.

Ligandal was founded in 2013. Ligandal is a genetic medicine company that uses nanotechnology to create targeted and personalized medicines. Ligandal is a regenerative medicine biotechnology business that develops ultra-rapid medicines and vaccinations for epidemics and pandemics, in addition to its work in immuno-oncology and rare genetic illnesses.

Do read about some of the most popular patents of Ligandal which have been covered by us in this article and also you can find Ligandal patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Ligandal patent portfolio.

How many patents does Ligandal have?

Ligandal has a total of 56 patents globally. These patents belong to 7 unique patent families. Out of 56 patents, 42 patents are active.

How Many Patents did Ligandal File Every Year?

Ligandal Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantLigandal Applications FiledLigandal Patents Granted
202331
20223
2021141
20203
201917
201716

How many Ligandal patents are Alive/Dead?

Worldwide Patents

Ligandal Patent Portfolio

How Many Patents did Ligandal File in Different Countries?

Ligandal Worldwide Patent Filing

Countries in which Ligandal Filed Patents

CountryPatent
United States Of America9
Japan8
Canada7
Israel6
Australia6
China6
Europe6

Where are Research Centers of Ligandal Patents Located?

The Research Center of Ligandal is in United States of America.

10 Best Ligandal Patents

US20180179553A1 is the most popular patent in the Ligandal portfolio. It has received 21 citations so far from companies like Mantra Bio, Regeneron Pharmaceuticals and Fluent Biosciences.

Below is the list of 10 most cited patents of Ligandal:

Publication NumberCitation Count
US20180179553A121
WO2018112282A19
WO2018112278A17
US20200208177A14
CN110582302A4
WO2019204531A14
US20200095605A13
CN112567032A3
CN112543650A3
US20200149070A13

What Percentage of Ligandal US Patent Applications Were Granted?

Ligandal (Excluding its subsidiaries) has filed 10 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 50%.

Below are the key stats of Ligandal patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Ligandal?

Law FirmTotal ApplicationsSuccess Rate
Perkins Coie Llp1050%

What are Ligandal key innovation segments?

What Technologies are Covered by Ligandal?

The chart below distributes patents filed by Ligandal in different countries on the basis of the technology protected in patents. It also represents the markets where Ligandal thinks it’s important to protect particular technology inventions.

R&D Focus: How has Ligandal search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Ligandal?

Related Articles

Celcem Patents – Insights & Stats (Updated 2024)

Celcem has a total of 28 patents globally, out of which all patents have been granted. Of these 28 patents, all patents patents are active. Singapore is where Celcem has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.